It is debatable just how quickly profitability is coming. I think some extra money from a vax deal would alleviate a lot of doubts about available cash reserves and likely result in a SP appreciation as there is reduced risk of needing to raise more funds. Of course, what would do better in my opinion is a bumper ADAPT quarter!
Does the vax deal matter?, page-2
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.66 |
Change
-0.495(4.07%) |
Mkt cap ! $251.5M | |||
| Open | High | Low | Value | Volume |
| $12.15 | $12.15 | $11.27 | $196.9K | 16.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 504 | $11.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.76 | 366 | 5 |
View Market Depth
| Last trade - 12.19pm 07/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |